Search

Connext TV

© Abbott 2023. All rights reserved. 9-EH-5-14558-01 09-2023
DGTHG 2023

Besuchen Sie die spannenden Symposien von Abbott Medical zu topaktuellen Themen. Wir freuen uns sehr, Sie an an unserem Ausstellungsstand Nr. D12 begrüßen zu dürfen. SONNTAG, 18. FEBRUAR 2024 |…
Connext Hub

© Abbott 2023. All rights reserved. 9-EH-5-14559-01 09-2023
Structural Heart

ENTDECKEN SIE UNSER PORTFOLIO Abbott hat ein einzigartiges Therapieangebot für strukturelle Herzerkrankungen. Ein breites Portfolio an Produkten in den Bereichen Transkatheter- und chirurgische…
Connext

ConnextTV Visit our dedicated channel for the latest videos, animations and interviews. Find out more Therapies Valvular Diseases …
AV Valves SUMMIT 2023

ON DEMAND AV VALVES SUMMIT 2023 1st global edition of the AtrioVentricular Valves Summit The inaugural edition of AV Valves Summit established a new platform for collaboration, exploration, and…
Patients who benefit

49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year…
Test page 3

TEST PAGE xxx SOLUTIONS TEST Check if your logged user sees the right products. CONTENT TEST Check if your logged user sees the right videos.
Overview

SWITCH TO THE REFERRAL VIEW For more information specific to neurology regarding LAA Occlusion REDUCE THE RISK OF STROKE, ELIMINATE ORAL ANTICOAGULANTS What is LAAO? Left…
Clinical Data

SWITCH TO THE REFERRAL VIEW For more information specific to neurology regarding LAA Occlusion STROKE RISK REDUCTION AND FREEDOM FROM ANTICOAGULANTS Clinical studies have shown…

Test page 3